Drugs plus ligation to prevent rebleeding in cirrhosis: an updated systematic review
Open Access
- 24 December 2013
- journal article
- research article
- Published by Wiley in Liver International
- Vol. 34 (6) , 823-833
Abstract
Background & Aims: Combined therapy with endoscopic variceal ligation (EVL) and β‐blockers ± isosorbide mononitrate (ISMN) is currently recommended to prevent variceal rebleeding. However, the role of this combined therapy has been challenged by some studies. We performed a systematic review to assess the value of combined therapy with EVL and β‐blockers ± ISMN as compared with each treatment alone to prevent rebleeding.Methods: Databases, references and meeting abstracts were searched to retrieve randomized trials comparing combined therapy with EVL and β‐blockers ± ISMN vs either treatment alone, to prevent variceal rebleeding in cirrhosis. Random‐effects model was used for meta‐analysis.Results: We identified five studies comparing EVL alone or combined with drugs, including a total of 476 patients. Combination therapy reduced overall rebleeding [risk ratios (RR) = 0.44, 95% confidence interval (CI) = 0.28–0.69], and showed a trend towards lower mortality (RR = 0.58, 95% CI = 0.33–1.03), without increasing complications. We identified four trials comparing drugs alone or associated with EVL, including 409 patients. All used β‐blockers plus ISMN. Variceal rebleeding decreased with combined therapy (P < 0.01) but rebleeding from oesophageal ulcers increased (P = 0.01). Overall, there was a trend towards lower rebleeding (RR = 0.76, 95% CI = 0.58–1.00) without effect on mortality (RR = 1.24, 95% CI = 0.90–1.70).Conclusions: The addition of drug therapy to EVL improves the efficacy of EVL alone. However, the addition of EVL to β‐blockers and ISMN achieves a non‐significant decrease of rebleeding with no effect on mortality. Although combination therapy with EVL plus β‐blockers ± ISMN is adequate to prevent rebleeding, β‐blockers + ISMN alone may be a valid alternative.Keywords
Funding Information
- Fondo de Investigaciones Sanitarias (PI10/01552)
- Fundació Investigació Sant Pau
This publication has 40 references indexed in Scilit:
- Endoscopic Band Ligation Versus Pharmacological Therapy for Variceal Bleeding in Cirrhosis: A Meta-AnalysisCanadian Journal of Gastroenterology and Hepatology, 2011
- Systematic review: secondary prevention with band ligation, pharmacotherapy or combination therapy after bleeding from oesophageal varicesAlimentary Pharmacology & Therapeutics, 2009
- Efficacy of β-adrenergic blocker plus 5-isosorbide mononitrate and endoscopic band ligation for prophylaxis of esophageal variceal rebleeding: A meta-analysisWorld Journal of Gastroenterology, 2009
- Combined Ligation and Sclerotherapy Versus Ligation Alone for Secondary Prophylaxis of Esophageal Variceal Bleeding: A Meta-AnalysisAmerican Journal of Gastroenterology, 2002
- Isosorbide mononitrate and propranolol compared with propranolol alone for the prevention of variceal rebleedingHepatology, 2000
- Endoscopic Treatments for Portal HypertensionSeminars in Liver Disease, 1999
- Nadolol plus Isosorbide Mononitrate Compared with Sclerotherapy for the Prevention of Variceal RebleedingNew England Journal of Medicine, 1996
- Endoscopic Ligation Compared with Sclerotherapy for Treatment of Esophageal Variceal BleedingAnnals of Internal Medicine, 1995
- The treatment of portal hypertension: A meta-analytic reviewHepatology, 1995
- Propranolol Compared with Propranolol plus Isosorbide-5-Mononitrate for Portal Hypertension in CirrhosisAnnals of Internal Medicine, 1991